Posaconazole oral dose and plasma levels in pediatric hematology‐oncology patients.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 3, p. 315, doi. 10.1111/ejh.13017
- By:
- Publication type:
- Article
Works matching IS 0902-4441 AND VI 100 AND IP 3 AND DT 2018
Results: 14
1
2
Outcome following second allogeneic hematopoietic cell transplantation: A single‐center experience.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 3, p. 308, doi. 10.1111/ejh.13015
- By:
- Publication type:
- Article
3
Thrombopoietin receptor agonists in patients with persistent or chronic immune thrombocytopenia.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 3, p. 304, doi. 10.1111/ejh.13014
- By:
- Publication type:
- Article
4
Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 3, p. 294, doi. 10.1111/ejh.13013
- By:
- Publication type:
- Article
5
Assessment of procoagulant potential in patients with reactive thrombocytosis and its association with platelet count.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 3, p. 286, doi. 10.1111/ejh.13012
- By:
- Publication type:
- Article
6
Flow cytometric analysis of cerebrospinal fluid in adult patients with acute lymphoblastic leukemia during follow‐up.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 3, p. 279, doi. 10.1111/ejh.13011
- By:
- Publication type:
- Article
7
DNA and RNA binding by the Wilms' tumour gene 1 (WT1) protein +KTS and −KTS isoforms—From initial observations to recent global genomic analyses.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 3, p. 229, doi. 10.1111/ejh.13010
- By:
- Publication type:
- Article
8
Falls in older adults with multiple myeloma.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 3, p. 273, doi. 10.1111/ejh.13009
- By:
- Publication type:
- Article
9
Cost‐utility analysis of idelalisib in combination with rituximab in relapsed or refractory chronic lymphocytic leukaemia.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 3, p. 264, doi. 10.1111/ejh.13007
- By:
- Publication type:
- Article
10
Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 3, p. 257, doi. 10.1111/ejh.13005
- By:
- Publication type:
- Article
11
Efficacy and tolerance of GELOXD/P‐GEMOXD in newly diagnosed nasal‐type extranodal NK/T‐cell lymphoma: A multicenter retrospective study.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 3, p. 247, doi. 10.1111/ejh.13004
- By:
- Publication type:
- Article
12
A historical perspective on milestones in multiple myeloma research.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 3, p. 221, doi. 10.1111/ejh.13003
- By:
- Publication type:
- Article
13
MONITOR‐GCSF DLBCL subanalysis: Treatment patterns/outcomes with biosimilar filgrastim for chemotherapy‐induced/febrile neutropenia prophylaxis.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 3, p. 241, doi. 10.1111/ejh.13002
- By:
- Publication type:
- Article
14
Issue Information.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 3, p. 219, doi. 10.1111/ejh.12945
- Publication type:
- Article